Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma (Q30661157)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma |
scientific article |
Statements
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma (English)
Tom Mikkelsen
Rakesh K Jain
Bart Neyns
Mario Campone
Antje Wick
Warren Mason
Surasak Phuphanich
Lynn S Ashby
John Degroot
Rao Gattamaneni
Lawrence Cher
Mark Rosenthal
Franz Payer
Juliane M Jürgensmeier
A Gregory Sorensen
John Xu